Pioneering cellular medicines for women’s health

Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers and endometriosis. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer and beyond.